首页|外周血NLR联合CD8+T淋巴细胞对乳腺癌患者保乳术后复发的预测价值

外周血NLR联合CD8+T淋巴细胞对乳腺癌患者保乳术后复发的预测价值

扫码查看
目的 分析外周血中性粒细胞与淋巴细胞比值(NLR)联合CD8+T淋巴细胞对乳腺癌患者保乳术后复发的预测价值。方法 选择宝鸡市妇幼保健院2016年2月至2019年2月就诊的乳腺癌患者106例,年龄(45。82±9。57)岁,肿瘤最大径(2。37±0。85)cm,所有患者均接受保乳手术治疗。术后随访5年,根据复发情况分为复发组与非复发组。对比复发组与非复发组外周血CD8+、NLR水平及临床资料,分析乳腺癌保乳术后复发的影响因素,外周血CD8+、NLR水平及二者联合对乳腺癌保乳术后复发的预测价值。采用t检验、x2检验、Fisher确切概率法,影响因素分析采用logistic回归模型。结果 随访5年,106例患者中失访3例,随访率为97。17%(103/106),复发12例,复发率为11。65%(12/103),未复发91例(88。35%,91/103)。复发组外周血CD8+水平低于非复发组[(23。17±3。36)%比(29。45±4。23)%],复发组外周血NLR水平高于非复发组[(2。64±0。39)比(1。72±0。24)],两组比较差异均有统计学意义(均P<0。05)。复发组淋巴结转移例数占比高于非复发组[58。33%(7/12)比24。18%(22/91)],复发组术后足程放疗、术后规范化疗例数占比低于非复发组[25。00%(3/12)比93。41%(85/91)、33。33%(3/12)比89。01%(81/91)],两组比较差异均有统计学意义(均P<0。05)。logistic回归分析结果显示,外周血 CD8+降低(OR=0。285,95%CI 0。125~0。647)、外周血 NLR 升高(OR=4。175,95%CI 1。835~9。796)、淋巴结转移(OR=5。013,95%CI2。204~11。403)、术后无足程放疗(OR=0。255,95%CI0。112~0。579)为乳腺癌保乳术后复发的影响因素(均P<0。05)。外周血CD8+、NLR水平及二者联合预测乳腺癌保乳术后复发的曲线下面积(AUC)分别为0。799、0。844、0。905,二者联合的AUC更高(P<0。05)。结论 外周血CD8+T淋巴细胞、NLR可用于预测乳腺癌患者保乳术后复发,且二者联合的预测价值更高。
Value of peripheral blood NLR combined with CD8+T lymphocytes in predicting recurrence of breast cancer patients after breast-conserving surgery
Objective To analyze the value of peripheral blood neutrophil to lymphocyte ratio(NLR)combined with CD8+T lymphocytes in predicting the recurrence of breast cancer patients after breast-conserving surgery.Methods A total of 106 patients with breast cancer who visited Baoji Maternal and Child Health Hospital from February 2016 to February 2019 were selected.They were(45.82±9.57)years old.The mean maximum tumor diameter was(2.3 7±0.85)cm.All the patients received breast-conserving surgery,and were followed up for 5 years.According to the recurrence situation,the patients were divided into a non-recurrence group and a recurrence group.The levels of peripheral blood CD8+,NLR's,and clinical data were compared between the recurrence group and the non-recurrence group.The factors influencing the recurrence of breast cancer after breast conserving surgery were analyzed.The values of peripheral blood CD8+,NLR,and their combination in predicting the recurrence of breast cancer after breast conserving surgery were analyzed.t test,x2 test,and Fisher exact probability method were used.The logistic regression model was used to analyzed the influencing factors.Results After 5 years'follow-up,3 of the 106 patients were lost to follow-up,and the follow-up rate was 97.17%(103/106).Of which,12 patients relapsed,and the recurrence rate was 11.65%(12/103);the remaining 91 patients did not relapse,and the recurrence rate was 88.35%(91/103).The level of peripheral blood CD8+in the recurrence group was lower than that in the non-recurrence group[(23.17±3.36)%vs.(29.45±4.23)%];the peripheral blood NLR in the recurrence group was higher than that in the non-recurrence group[(2.64±0.39)vs.(1.72±0.24)];there were statistical differences between the two groups(both P<0.05).The proportion of the patients with lymph node metastasis in the recurrence group was higher than that in the non-recurrence group[58.33%(7/12)vs.24.18%(22/91);P<0.05];the proportions of the patients taking postoperative full-course radiotherapy and standard chemotherapy in the recurrence group were lower than those in the non-recurrence group[25.00%(3/12)vs.93.41%(85/91)and 33.33%(3/12)vs.89.01%(81/91);both P<0.05].The logistic regression analysis showed that peripheral blood CD8+decrease(OR=0.285,95%CI 0.125-0.647),peripheral blood NLR increase(OR=4.175,95%CI 1.835-9.796),lymph node metastasis(OR=5.013,95%CI 2.204-11.403),and postoperative full-course radiotherapy(OR=0.255,95%CI 0.112-0.579)were the influential factors for breast cancer recurrence after breast conserving surgery(all P<0.05).The areas under the curves(AUC)of peripheral blood CD8+,NLR,and their combination in predicting breast cancer recurrence after breast preservation surgery were 0.799,0.844,and 0.905,respectively,and the AUC of the combination was higher(P<0.05).Conclusion Peripheral blood CD8+T lymphocytes and NLR can be used to predict the recurrence of breast cancer patients after breast-conserving surgery,and the combined value is higher.

Breast cancerCD8+T lymphocytesNeutrophil to lymphocyte ratioBreast-conserving surgeryRecurrencePrediction

吴庆华、郝红、李雪雪、韩晨博

展开 >

宝鸡市妇幼保健院检验科,宝鸡 721000

宝鸡市妇幼保健院乳腺外科,宝鸡 721000

乳腺癌 CD8+T淋巴细胞 中性粒细胞与淋巴细胞比值 保乳手术 复发 预测

陕西省自然科学基础研究计划

2020JM-393

2024

国际医药卫生导报
中华医学会,国际医药卫生导报社

国际医药卫生导报

影响因子:0.781
ISSN:1007-1245
年,卷(期):2024.30(15)
  • 5